← Open Payments lookup

JAYSON GESULGA: Open Payments

NPI 1972989721 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$299,643 in 574 payments from 14 companies in 2025. Trend: 2023 $166,749 · 2024 $258,559 · 2025 $299,643

Speaker / faculty: $222,015Travel & lodging: $56,394Consulting: $11,868Food & beverage: $9,225Education: $141
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)172$102,111
Neurocrine BioSciences, Inc.170$86,248
Teva Pharmaceuticals USA, Inc.89$58,965
Alkermes, Inc.47$21,186
E.R. Squibb & Sons, L.L.C.36$17,007
ABBVIE INC.29$10,855
Otsuka America Pharmaceutical, Inc.17$2,780
Axsome Therapeutics, Inc.4$289
Otsuka Pharmaceutical Development & Commercialization, Inc.3$56
Lundbeck LLC2$42

Products named: CAPLYTA, INGREZZA, AUSTEDO XR, LYBALVI, COBENFY, VRAYLAR, UZEDY, ABILIFY MAINTENA.

Industry payments across IA — which companies pay providers there.